Company / Working Capital
Celularity Inc Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$68.4M
FY2025
5-year range
-$68.4M / $32.9M
FY2021-FY2025
Trend
-106.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$48M to -$68M over the past 2 years.
Based on SEC 10-K filings.
-$68M in FY2025.
Declined from -$48M to -$68M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 106.6% year-over-year.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$68.4M | -106.6% |
| FY2024 | -$33.1M | +30.3% |
| FY2023 | -$47.5M | -66.2% |
| FY2022 | -$28.6M | -187.0% |
| FY2021 | $32.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026